Biden Asia chief 'relatively confident' on billion vaccine timing despite India crisis | The Daily Star
08:10 AM, June 09, 2021 / LAST MODIFIED: 08:14 AM, June 09, 2021

Biden Asia chief 'relatively confident' on billion vaccine timing despite India crisis

President Joe Biden's Indo-Pacific policy chief said on Tuesday he was "relatively confident" a target for the production of a billion vaccine doses for the region by the end of 2022 would be met, despite the Covid-19 crisis in India, where they are due to be made.

Asked at an event hosted by the Center for a New American Security think tank if he expected a delay in the four-nation plan, which was announced at the White House in March with great fanfare, Kurt Campbell said Washington had been in close consultation with India and others involved in the project.

For all latest news, follow The Daily Star's Google News channel.

"Obviously, this is an extremely difficult period for Indian friends. The United States has tried to stand with Delhi and to bring others, both in the private and public sector, to support them," he said.

"Our discussions with both our partners in the private sector, and also in government, suggest that we are - knock on wood - still on track for 2022."

"I think we're feeling relatively confident as we head in to 2022," he added, while stressing that across Asia and the world even countries that did well in handling the virus were facing outbreaks due to new strains.

"I think we understand, the only way to be effective, to counter this, is through vaccine diplomacy. We're trying to step that up more generally," he said.

The so-called Quad grouping of the United States, India, Japan and Australia agreed at a March summit that Indian drugmaker Biological E Ltd would produce at least a billion vaccine doses by the end of 2022 that would go to Southeast Asian countries, elsewhere in the Indo-Pacific, and beyond.

US officials said that under the plan the United States and Japan would help Indian manufacturing of vaccines for US drugmakers Novavax Inc and Johnson & Johnson.

India, the world's largest vaccine producer, was subsequently hit by a catastrophic wave of infections and halted vaccine exports amid intense criticism of Prime Minister Narendra Modi for a domestic vaccine rollout that covered less than 5 percent of an estimated adult population of 950 million.

Indian government sources told Reuters in May India was unlikely to resume major exports of vaccines until at least October. On Tuesday, Indian officials and health experts welcomed a government plan to give free shots to all adults, but cautioned that vaccinations must be accelerated to prevent new surges in infections.

Stay updated on the go with The Daily Star Android & iOS News App. Click here to download it for your device.

Grameenphone:
Type START <space> BR and send SMS it to 22222

Robi:
Type START <space> BR and send SMS it to 2222


Banglalink:
Type START <space> BR and send SMS it to 2225

Leave your comments

Top News

Top News

Top